Huasheng group Xi Anhua sheng

Xi Anhuasheng Bio-pharmaceutical Co., Ltd. is the only wholly foreign-owned enterprise invested and established by American Watson Group in Chinese mainland. Approved by Xi People's Government, it was incorporated in Xi 'an High-tech Industrial Development Zone on April 6, 1997 with a registered capital of/kloc-0.05 million yuan. The total investment is more than 20 million yuan. The company integrates science, industry and trade, and is a comprehensive company dedicated to the research, production, sales and trade of biomedicine, health care products and medical devices, as well as the digestion, absorption and promotion of scientific and technological achievements.

The company has 60 employees, including management and scientific research technicians 18, production personnel 18, marketing managers18, and expert consultants, including 8 with senior titles and 23 with intermediate titles. College degree or above accounted for 62%, and all production workers graduated from technical secondary schools. The company has administrative personnel department, quality department, production technology department, sales department, marketing department, finance department and R&D department. The company advocates the business philosophy of "science and technology promote development" and pays attention to talent construction. Relying on the advantages of the group, the company introduced the advanced management mode of the United States, and combined with the actual situation in China, established a set of management system and market operation rules with sound system, perfect risk prevention mechanism, rules to follow, strong financial strength, leading technological advantages, high starting point operation and high standards. In just a few years, the company has established a good corporate image in the society with its products with outstanding curative effect and high-quality and efficient service. The company's decision-makers have a sense of being ahead of the times, and all employees are proactive, thus establishing an authoritative image of "cleaning blood vessels" in all walks of life.

Combining modern science and technology with traditional Chinese medicine, the company has developed 10 kinds of high-tech products for the market. At present, the company has independently developed the national third-class new drug "Xuezhiping Soft Capsule" and obtained clinical approval; At the same time, various raw materials and health foods are being developed.

In the market, the company draws lessons from the experience of the group, adopts advanced marketing theory, takes high technology as the backing, takes Pandakang soft capsules as the fist product (all its finished products are made in the United States), applies advanced marketing concepts and strategies, pays attention to network talents, and relies on scientific and technological progress and scientific management to actively build a sales network and expand the national market. In the market competition, the economic benefits have doubled and always maintained a high-speed leap-forward development trend. At present, the company is fully responsible for the market operation of the group's headquarters in Chinese mainland, covering the whole country.

Xi Anhuasheng Bio-pharmaceutical Co., Ltd. aims at "protecting human health, benefiting civilized society and supporting the construction of the western region", taking science and technology as the guide, relying on the development, research, production and technical services of new products, pursuing the high-tech content of products, carrying forward the essence of national medicine, creating first-class products, being down-to-earth and opening up the future as the goal.